Digital exercise program for patients with spondyloarthritis
Official title: The SPARK Trial: a Digital Exercise Intervention in Patients With Spondyloarthritis
Run by Diakonhjemmet Hospital · NCT06462937 · Data updated 2026-11-12
This study is testing a digital exercise program to see if it helps people with axial spondyloarthritis feel better compared to regular care.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 260 (estimated) |
| Sponsor | Diakonhjemmet Hospital Academic / other |
| Locations | 1 site (Oslo) |
| Status | Recruiting |
| Started | July 1, 2024 |
| Main results expected | August 1, 2027 |
| Study ends | August 1, 2030 |
| Registry record updated | August 20, 2026 |
| Trial ID | NCT06462937 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults over 18 with a recent diagnosis of axial spondyloarthritis and active disease who have not previously used biologic disease-modifying anti-rheumatic drugs.
✕Probably not a fit
Patients with active iridocyclitis, high C-reactive protein levels, or contraindications to high intensity exercise may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical trial evaluates a 6-month randomized controlled exercise intervention for patients with axial spondyloarthritis (axSpA). Participants will be assigned to either a digital exercise program delivered via the SPARK application, which includes high intensity interval training and personalized remote follow-up, or to usual care. The primary goal is to assess the impact of this tailored exercise program on disease activity, measured by the ankylosing spondylitis disease activity score (ASDAS), at the 3-month mark. The program aims to empower patients through knowledge videos and structured exercise sessions to improve their overall health and well-being.
Why it matters
Potential benefit: If successful, this intervention could significantly reduce disease activity in patients with spondyloarthritis, improving their quality of life.
How similar studies have gone: Other studies have shown promise with digital exercise interventions for chronic conditions, suggesting potential success for this approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * axSpA diagnosis within the last two years by a rheumatologist according to the ASAS criteria of 2009 * active disease (ASDAS \> 1.3) Exclusion Criteria: * Active uveitis. * CRP \> 30. * Former or current use of bDMARDs. * Pregnancy or planned pregnancy within 6 months from inclusion. * Absolute and relative contradictions to high intensity exercise according to the American College of Sports Medicine (ACSM) * Other serious disease such as cancer. * Patients incapable to follow the protocol or the control set-up with remote monitoring.
Where it's running
-
Diakonhjemmet hospital
Oslo, Norway Recruiting
Study contacts
- Study coordinator: Sella A Provan, Professor
- Email: SellaProvan@gmail.com
- Phone: 4791582581
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Impact of ultra-processed foods on rheumatic diseases
This study looks at how eating ultra-processed foods might affect people with chronic rheumatic diseases like rheumatoid arthritis and osteoarthritis to see if it makes their symptoms worse.
-
Fecal microbiota transplantation for treating axial spondyloarthritis
This study is testing if a treatment using gut bacteria from healthy donors can help people with axial spondyloarthritis who aren't feeling better with their current medications.
-
Exploring the role of IL-23 in spondyloarthritis
This study is trying to see how a protein called IL-23 affects immune cells in people with spondyloarthritis to better understand the disease and its different types.
-
Biobank for patients with inflammatory chronic diseases and osteoporosis
This study is creating a biobank to collect samples from patients with chronic inflammatory diseases and osteoporosis to see if they can find markers that help doctors choose better treatments.
-
Gut bacteria test to predict response to biologic treatment in spondyloarthritis
This project will test whether gut bacteria in stool samples can predict if anti-TNF or anti-IL-17 biologic treatment will work for adults with spondyloarthritis.
-
Exploring the link between gut bacteria and spondyloarthritis
This study is testing if a specific gut bacteria called Ruminococcus gnavus is linked to spondyloarthritis by comparing patients with the condition to healthy people.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.